Verification is fast and easy - just sign up and follow the prompts.
06/20 - Ceros Capital Markets acted as exclusive placement agent for a significant portion in Dermasensor's Series A financing Read more »
06/20 - Ceros Capital Markets acted as exclusive placement agent for a significant portion in Dermasensor's Series A financing Read more »
In June 2019, Chris Dewey, Mark Goldwasser, and David Brown acquired Ceros Financial Services, Inc.
Since this acquisition, the Ceros Capital Markets division has focused on robotic surgery and minimally invasive, non-intrusive medical device companies and has successfully completed the following transactions:
3.7M
TriFlo Cardiovascular is a biotechnology firm working in stealth mode.
+$5M
OrthoSensor is a medical device company developing devices and data services for the orthopedic sector.
+$10M
Develops and manufactures MR-guided focused ultrasound devices for image-guided acoustic surgery.
+$7M
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective...
Prior to joining Ceros, Chris Dewey had a long history of investing In companies with a valuation under $20 Million, many of which, at the time he invested, were valued under $10 Million. The value of the five companies is over $10 Billion.
+$1.4B
Developing the Lithoplasty™ family of balloon dilatation catheters that incorporate tiny lithotripsy electrodes shock.
+$5B
Auris Health is a medical company that develops robotics technology for medical applications.
+$500M
PROCEPT BioRobotics is a clinical-stage medical device company based in Silicon Valley
+ $1.65B
MAKO Surgical is a medical device company specializing in robotic-arm assisted surgery in orthopedics.
+$12M
Cephea Valve Technologies, Inc. provides catheter delivered mitral valve regurgitation products/heart
* valuations provided are as of 7/1/2020